NDC 58354-117
Dyrax-Q Tab
Bisacodyl, Docusate Sodium
Dyrax-Q Tab is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Cho-a Pharm.co.,ltd.. The primary component is Bisacodyl; Docusate Sodium.
| Product ID | 58354-117_95fe3aa6-6654-64bf-e053-2995a90ab91c |
| NDC | 58354-117 |
| Product Type | Human Otc Drug |
| Proprietary Name | Dyrax-Q Tab |
| Generic Name | Bisacodyl, Docusate Sodium |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-10-25 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Cho-A Pharm.Co.,Ltd. |
| Substance Name | BISACODYL; DOCUSATE SODIUM |
| Active Ingredient Strength | 5 mg/161mg; mg/161mg |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |